Matthias Van Woensel
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Tumor Targeting by Peptide-Decorated Gold Nanoparticles.
Journal: Molecular pharmaceutics
Published: April 11, 2019
New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Journal: Molecular pharmaceutics
Published: January 18, 2018
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth.
Journal: EMBO molecular medicine
Published: October 18, 2017
Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis.
Journal: The Journal of allergy and clinical immunology
Published: February 10, 2017
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy.
Journal: Scientific reports
Published: January 06, 2017
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma.
Journal: Oncoimmunology
Published: December 09, 2016
Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.
Journal: Cell death and differentiation
Published: November 14, 2016
Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
Journal: Stem cells translational medicine
Published: January 15, 2016
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy.
Journal: International journal of pharmaceutics
Published: November 16, 2015
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 13, 2015
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.
Journal: Frontiers in immunology
Published: September 30, 2015
Last Updated: 09/26/2026